Associate editor: M.K. PugsleyCommon pathophysiological mechanisms of chronic kidney disease: Therapeutic perspectives
Section snippets
Introduction to chronic renal disease
Chronic kidney disease (CKD) is a life-threatening condition characterized by progressive and irreversible loss of renal function. The increasing inability of the kidneys to properly clear the blood of waste products eventually results in the implementation of dialysis (or kidney transplant) in order to prevent azotemia, systemic organ damage and death. Due to its high prevalence and associated mortality, CKD is an important human and social burden. It is estimated that over 10% of adults in
Hypertensive nephropathy
Hypertension is the second leading cause of end-stage renal disease (ESRD). As an example, according to the United States Renal Data System (U.S. Renal Data System, 2009), about 51–63% of all patients with CKD are hypertensive. This number grows to 90% in patients over 65 years. In the corresponding general population the incidence of hypertension is 11–13% and 50%, respectively. Hypertension causes a nephrosclerotic glomerulopathy characterized by (i) renal vasculopathy affecting preglomerular
Pathophysiology of diabetic renal damage
Diabetic nephropathy is the most common glomerulopathy, and the leading cause of ESRD in the USA and Europe (Molitch et al., 2004). In fact, about 50% of ESRD patients (in the USA) are diabetic (U.S. Renal Data System, 2009). It is important to consider that hyperglycemia is a primary initiator of diabetic nephropathy. In the absence of elevated glycemia, nephropathy does not develop. However, diabetic nephropathy holds a genetic component at two levels: first, the elevation of glycemia; and
Renal mass reduction
Regardless of etiology, the number of nephrons decreases during the progression of CKD. The space formerly occupied by glomeruli and tubuli becomes replaced with an extracellular matrix through a fibrotic process largely resembling scarring (Garber et al., 2003, Prieto et al., 2005). The remaining nephrons increase their filtration rate in order to maintain the excretory need of the organism. Renal dysfunction appears when the remaining nephrons cannot cope with the sustained extra load.
Obstructive nephropathy
Obstruction of the urinary pathway (chiefly resulting from blockade of one or, exceptionally, both ureters) causes progressive deterioration of renal structures leading to chronic dysfunction. Ureteral obstruction gives rise to the hydronephrotic syndrome, characterized by kidney enlargement due to urine collection in the renal pelvis or calyces (Mendelsohn, 2004). It appears clinically as decreased renal function due to anatomical or functional abnormalities compromising urine flow through the
Common mechanisms of progression
Animal models have provided valuable insights into the pathogenesis of chronic kidney diseases. They have proved to be extremely useful for studying and understanding the pathogenetic mechanisms involved in their onset and progression, and for testing new treatments. Knowledge gathered from animal models increases our understanding of human pathology, which in turn helps us to develop new and more specific animal models in which to evaluate novel therapeutic interventions at the preclinical
Renin–angiotensin aldosterone system inhibition
RAAS inhibition has proved to be the most effective therapy at reducing proteinuria and slowing CKD progression in animals and humans (Perico et al., 2008). Furthermore, RAAS inhibition has proved to cause regression and repair of certain apects of CKD, such as glomerular fibrosis, in experimental models (Fogo, 2006a, Fogo, 2006b, Remuzzi et al., 2006).
Angiotensinogen is cleaved by the enzyme renin into the decapeptide angiotensin I, which in turn is cleaved by the zinc metallopeptidase
Therapeutic perspectives
The horizon for the clinical handling of CKD may be analyzed from different perspectives. First, diagnosis must be improved for an earlier detection of progression and for identification of prognostic markers that anticipate which patients will progress more rapidly than others. Second, new forms of therapy are needed to improve our capacity to slow and even halt progression, and to reverse the damage and regenerate renal tissues.
Final remarks
A greater specific knowledge regarding the pathophysiological mechanisms underlying the inception, transformation and progression of pathologies that lead to the development of chronic kidney disease is expected to enable, in the near future, the development of better and earlier diagnostics. This, in turn, should provide a better clinical management of disease progression in order to prevent the need for renal replacement therapy (RRT) or secondary health complications during the patient's
References (323)
- et al.
Inhibition of TGF-beta 1 expression by antisense oligonucleotides suppressed extracellular matrix accumulation in experimental glomerulonephritis
Kidney Int
(1996) - et al.
Vascular catabolism of bradykinin in the isolated perfused rat kidney
Eur J Pharmacol
(2000) - et al.
Obstructive nephropathy: Insights from genetically engineered animals
Kidney Int
(2005) - et al.
The renin–angiotensin–aldosterone system and the kidney: effects on kidney disease
Am J Med
(2004) - et al.
Specific inhibition of Egr-1 prevents mesangial cell hypercellularity in experimental nephritis
Kidney Int
(2003) - et al.
Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy
Kidney Int
(2009) - et al.
Glucose and diabetes: Effects on podocyte and glomerular p38MAPK, heat shock protein 25, and actin cytoskeleton
Kidney Int
(2006) - et al.
Renal disease profoundly alters cortical interstitial cell function
Kidney Int
(1983) - et al.
The kidney, a cardiovascular risk marker, and a new target for therapy
Kidney Int Suppl
(2005) Macrophages and progressive renal disease in experimental hydronephrosis
Am J Kidney Dis
(1995)
Regulation of proximal tubular osteopontin in experimental hydronephrosis in the rat
Kidney Int
Attenuation of folic acid-induced renal inflammatory injury in platelet-activating factor receptor-deficient mice
Am J Pathol
Activation of a local tissue angiotensin system in podocytes by mechanical strain
Kidney Int
Ureteropelvic junction obstruction causes histologic alterations in contralateral kidney
J Pediatr Surg
Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model
Kidney Int
An integrative view on the role of TGF-β in the progressive tubular deletion associated to chronic kidney disease
Kidney Int
Pathological expression of renin and angiotensin II in the renal tubule after subtotal nephrectomy. Implications for the pathogenesis of tubulointerstitial fibrosis
Am J Pathol
Deletion of H-Ras decreases renal fibrosis and myofibroblast activation following ureteral obstruction in mice
Kidney Int
Connective tissue growth factor: Potential role in glomerulosclerosis and tubulointerstitial fibrosis
Kidney Int
Tissue engineering the kidney
Kidney Int
HGF gene therapy attenuates renal allograft scarring by preventing the profibrotic inflammatory-induced mechanisms
Kidney Int
Calcium anagonist drugs
N Engl J Med
Nitric oxide/endothelin balance after nephron reduction
Kidney Int Suppl
In search of adult renal stem cells
J Cell Mol Med
Mesangial AT1 receptors: Expression, signaling, and regulation
J Am Soc Nephrol
Ultrastructural changes in the remnant kidney (after 5/6 nephrectomy) glomerulus after losartan and atenolol treatment
Medicina (Kaunas)
Renin inhibition with aliskiren: where are we now, and where are we going?
J Hypertens
Prevention of cyclosporin nephrotoxicity with a platelet-activating factor (PAF) antagonist
Nephrol Dial Transplant
Mechanical stretch/relaxation stimulates a cellular renin–angiotensin system in cultured rat mesangial cells
Exp Nephrol
Generation of reactive oxygen species by endothelial and smooth muscle cells: Influence of hyperglycemia and metformin
Horm Metab Res
Altered vascular reactivity following partial nephrectomy in the rat: A possible mechanism of the blood-pressure-lowering effect of heparin
Nephrol Dial Transplant
Changing trends in pedriatric transplantation: 2001 annual report of the north american pediatric renal transplant cooperative study
Pediatr Transplant
Signal transduction pathways of angiotensin II in the kidney
Contrib Nephrol
Angiotensin receptors: Signaling, vascular pathophysiology, and interactions with ceramide
Am J Physiol Heart Circ Physiol
Marrow stromal stem cells
J Clin Invest
“Step” vs. “dynamic” autoregulation: Implications for susceptibility to hypertensive injury
Am J Physiol Ren Physiol
Lisofylline, a novel antiinflammatory compound, protects mesangial cells from hyperglycemia- and angiotensin II-mediated extracellular matrix deposition
Endocrinology
Dedifferentiation and proliferation of surviving epithelial cells in acute renal failure
J Am Soc Nephrol
Age-dependent glomerulosclerosis and proteinuria occurring in rats of the Milan normotensive strain and not in rats of the Milan hypertensive strain
Lab Invest
Nephron adaptation to renal injury or ablation
Am J Physiol
Attenuation of interstitial fibrosis and tubular apoptosis in db/db transgenic mice overexpressing catalase in renal proximal tubular cells
Diabetes
Stem cell approaches for the treatment of renal failure
Pharmacol Rev
ACE inhibition versus angiotensin type 1 receptor antagonism: differential effects on PAI-1 over time
Hypertension
Renal disease susceptibility and hypertension are under independent genetic control in the fawn-hooded rat
Nat Genet
Time course and localization of endothelin-1 gene expression in a model of renal disease progression
Am J Pathol
Mechanism of matrix accumulation and glomerulosclerosis in spontaneously hypertensive rats
J Hypertens
Angiotensin type 2 receptor antagonism confers renal protection in a rat model of progressive renal injury
J Am Soc Nephrol
Insights into the mechanisms of renal fibrosis: Is it possible to achieve regression?
Am J Physiol Ren Physiol
Therapy for acute pancreatitis with platelet-activating factor receptor antagonists
World J Gastroenterol
Pathophysiology of obstructive nephropathy in the newborn
Semin Nephrol
Cited by (130)
Inhibition of TRPC6 suppressed TGFβ-induced fibroblast-myofibroblast transdifferentiation in renal interstitial NRK-49F cells
2022, Experimental Cell ResearchMacrophages polarization in renal inflammation and fibrosis animal models (Review)
2024, Molecular Medicine ReportsRecent advances of CREKA peptide-based nanoplatforms in biomedical applications
2023, Journal of NanobiotechnologyMeasured GFR in murine animal models: review on methods, techniques, and procedures
2023, Pflugers Archiv European Journal of Physiology